Why Test for Sexually Transmitted Infections with the IMP Diagnostics STI Panel?
Sexually transmitted infections (STIs) represent a global public health problem, with currently alarming figures:
📊 1 million STIs acquired every day, often without symptoms.
📈 374 million new infections annually caused by chlamydia, gonorrhea, syphilis, and trichomoniasis.
The panel we provide makes your clinical practice more proactive and effective in the early diagnosis of STIs. Our panel is highly versatile, capable of providing high-quality results for samples from the male and female anogenital region, as well as samples from the skin, oral cavity, and urine. Add value and effectiveness to your diagnosis and promote an effective response in the prevention and treatment of STIs by trusting IMP Diagnostics.
You might like: IMP Diagnostics as Part of the History of Pathology.